Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase

SOUTHLAKE, Texas, Sept. 24, 2026 /PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participati…

Summary from PR Newswire - Clinical Trials.

Coverage 1 article · 1 outlet

1. PR Newswire - Clinical Trials 3h ago
   Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase ↗